Abstract: Background and Objectives: Aneurysms in the cavernous segment of the internal carotid artery (ICA) often present in an indolent fashion with limited morbidity. However, their growth progression and possible rupture over time remains poorly defined, thereby limiting optimization of serial follow-up. Thus, we aim to describe the progression of cavernous ICA aneurysms over time, as well as the patient and aneurysm characteristics associated with possible growth and rupture status.
Methods: We identified a consecutive cohort of 157 patients from 2007 to 2021 with cavernous ICA aneurysms. Patient demographic data, possible risk factors, presenting symptoms, radiographic features of aneurysms, size progression, rupture status, and concomitant noncavernous aneurysm rupture data were manually extracted.
Results: One hundred and fifty-seven patients (mean age at diagnosis 57.2 ± 15.6 years; 85.4% females) with 174 cavernous carotid aneurysms (CCAs) were followed for an average of 7.1 ± 4.8 years. 76.4% of aneurysms were identified incidentally, with predominantly ocular palsies as the presenting symptoms in remaining primary cases. Most aneurysms were small, and of the 168 aneurysms that were followed, 98.2% did not demonstrate appreciable growth. Of the aneurysms that grew, it took an average of 6.0 years to grow 1.6 ± 0.2 mm. Demographic data, hypertension, and smoking status were not associated with aneurysm growth. Most radiographic features also were not associated with growth, except long-axis diameter, which had an odds ratio of 1.4 (CI: 1.2, 1.8) on multivariable analysis. Presenting clinical symptoms were not associated with growth. No CCAs ruptured during follow-up.
Conclusion: Cavernous ICA aneurysms in our series demonstrate no rupture and limited growth over years of clinical follow-up. No radiographic or patient risk factors were associated with growth except initial aneurysm size. Hence, small CCAs may not require close follow-up over time.
(Copyright © Congress of Neurological Surgeons 2024. All rights reserved.)
References: Eddleman CS, Hurley MC, Bendok BR, Batjer HH. Cavernous carotid aneurysms: to treat or not to treat? Neurosurg Focus. 2009;26(5):e4.
Stiebel-Kalish H, Kalish Y, Bar-On RH, et al. Presentation, natural history, and management of carotid cavernous aneurysms. Neurosurgery. 2005;57(5):850-857; discussion 850-857.
Dacus MR, Nickele C, Welch BG, et al. Matricidal cavernous aneurysms: a multicenter case series. J Neurointerv Surg. 2019;11(6):584-590.
Wiebers DO, Whisnant JP, Huston J, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103-110.
Haase A, Schob S, Quäschling U, Richter C, Meixensberger J, Nestler U. Intracavernous de novo aneurysms without prior manipulation of the harboring vessel: report of two cases. OJMN. 2020;10(01):167-174.
Vukov JG. Intracavernous aneurysm with isolated 6th nerve palsy. Ann Ophthalmol. 1975;7(8):1071-1074.
Rebella G, Basso L, Federici M, Castaldi A. Recurrent epistaxis of unknown origin: the role of imaging. Acta Neurol Taiwan. 2019;28(4):126-130.
Ghorbani M, Hejazian SE, Dastmalchi A, Chavoshinejad M, Asaadi S. Orbital compartment syndrome secondary to direct carotid cavernous fistula after carotid cavernous aneurysm rupture: case report and review of literature. World Neurosurg. 2020;133:409-412.
Kupersmith MJ, Stiebel-Kalish H, Huna-Baron R, et al. Cavernous carotid aneurysms rarely cause subarachnoid hemorrhage or major neurologic morbidity. J Stroke Cerebrovasc Dis. 2002;11(1):9-14.
de Vasconcellos LP, Flores JAC, Veiga JCE, Conti MLM, Shiozawa P. Presentation and treatment of carotid cavernous aneurysms. Arq Neuropsiquiatr. 2008;66(2A):189-193.
Gagliardi D, Faravelli I, Villa L, et al. Bilateral cavernous carotid aneurysms: atypical presentation of a rare cause of mass effect. A case report and a review of the literature. Front Neurol. 2018;9:619.
Kupersmith MJ, Hurst R, Berenstein A, Choi IS, Jafar J, Ransohoff J. The benign course of cavernous carotid artery aneurysms. J Neurosurg. 1992;77(5):690-693.
Menon S, Menon RG. Cavernous carotid aneurysms: to do or not to do? J Neurosci Rural Pract. 2017;8(2):284-287.
Goldenberg-Cohen N, Curry C, Miller NR, et al. Long term visual and neurological prognosis in patients with treated and untreated cavernous sinus aneurysms. J Neurol Neurosurg Psychiatry. 2004;75(6):863-867.
Dolenc VV. Extradural approach to intracavernous ICA aneurysms. Acta Neurochir Suppl. 1999;72:99-106.
Weber W, Bendszus M, Kis B, Boulanger T, Solymosi L, Kühne D. A new self-expanding nitinol stent (enterprise) for the treatment of wide-necked intracranial aneurysms: initial clinical and angiographic results in 31 aneurysms. Neuroradiology. 2007;49(7):555-561.
Ambekar S, Madhugiri V, Sharma M, Cuellar H, Nanda A. Evolution of management strategies for cavernous carotid aneurysms: a review. World Neurosurg. 2014;82:1077-1085.
Linskey ME, Sekhar LN, Hirsch WL, Yonas H, Horton JA. Aneurysms of the intracavernous carotid artery: natural history and indications for treatment. Neurosurgery. 1990;26(6):933-938; discussion 937-938.
Seinfeld J, Karim S. Cavernous sinus aneurysm. StatPearls Publishing; 2023. Accessed July 11, 2023. http://www.ncbi.nlm.nih.gov/books/NBK430840/.
Silva MA, See AP, Dasenbrock HH, Patel NJ, Aziz-Sultan MA. Vision outcomes in patients with paraclinoid aneurysms treated with clipping, coiling, or flow diversion: a systematic review and meta-analysis. Neurosurg Focus. 2017;42(6):e15.
Moon E, Park W, Song Y, Lee DH, Ahn JS, Park JC. Mass effect after flow diversion for unruptured large and giant cavernous or paraclinoid internal carotid artery aneurysm. World Neurosurg. 2023;180:e108-e116.
Rinkel GJE. Natural history, epidemiology and screening of unruptured intracranial aneurysms. Rev Neurol (Paris). 2008;164(10):781-786.
Fehrenbach MK, Dietel E, Wende T, et al. Management of cavernous carotid artery aneurysms: a retrospective single-center experience. Brain Sci. 2022;12(3):330.
Rosi Junior J, Welling LC, Yeng LT, et al. Cavernous carotid artery aneurysms: epidemiology, natural history, diagnostic and treatment. An experience of a single institution. Clin Neurol Neurosurg. 2014;125:32-35.
Kumar A, Kutty RK, Yamada Y, et al. A retrospective analysis of treatment outcomes of 40 incidental cavernous carotid aneurysms. World Neurosurg. 2019;130:e1034-e1040.
Lee AG, Mawad ME, Baskin DS. Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm: case report. Neurosurgery. 1996;38(3):596-599; discussion 598-599.
Sudhoff H, Stark T, Knorz S, Luckhaupt H, Borkowski G. Massive epistaxis after rupture of intracavernous carotid artery aneurysm. Case report. Ann Otol Rhinol Laryngol. 2000;109(8 Pt 1):776-778.
Penchet G, Mourier K. Collaborative retrospective multicentre series of giant intracavernous carotid aneurysms. Neurochirurgie. 2015;61(6):366-370.
Durner G, Piano M, Lenga P, et al. Cranial nerve deficits in giant cavernous carotid aneurysms and their relation to aneurysm morphology and location. Acta Neurochir (Wien). 2018;160(8):1653-1660.
Vercelli G, Sorenson TJ, Aljobeh AZ, Vine R, Lanzino G. Cavernous sinus aneurysms: risk of growth over time and risk factors. J Neurosurg. 2019;132(1):22-26.
Li W, Sun Q, Duan X, et al. Etiologies and risk factors for young people with intracerebral hemorrhage [in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(11):1246-1250.
Processing Request
No Comments.